Aarsland D, Litvan I, Larsen JP (2001) Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson’s disease. J Neuropsychiatry Clin Neurosci 13:42–49

Article  CAS  PubMed  Google Scholar 

Ahmad MH, Rizvi MA, Ali M, Mondal AC (2023) Neurobiology of depression in Parkinson’s disease: Insights into epidemiology, molecular mechanisms and treatment strategies. Ageing Res Rev 85:101840

Article  CAS  PubMed  Google Scholar 

Albrecht F, Bisenius S, Morales Schaack R, Neumann J, Schroeter ML (2017) Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses. NPJ Parkinsons Dis 3:12

Article  PubMed  PubMed Central  Google Scholar 

Ali F, Whitwell JL, Martin PR, Senjem ML, Knopman DS, Jack CR, Lowe VJ, Petersen RC, Boeve BF, Josephs KA (2018) [(18)F] AV-1451 uptake in corticobasal syndrome: the influence of beta-amyloid and clinical presentation. J Neurol 265:1079–1088

Article  CAS  PubMed  PubMed Central  Google Scholar 

Almeida L, Ahmed B, Walz R, De Jesus S, Patterson A, Martinez-Ramirez D, Vaillancourt D, Bowers D, Ward H, Okun MS, McFarland NR (2017) Depressive symptoms are frequent in atypical parkinsonian disorders. Mov Disord Clin Pract 4:191–197

Article  PubMed  Google Scholar 

American, Psychiatric, Association, Association AP (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th edn. American Psychiatric Publishing, Washington, DC

Book  Google Scholar 

Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, Riley DE, Tolosa E, Troster AI, Vidailhet M, Weiner WJ (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496–503

Article  PubMed  PubMed Central  Google Scholar 

Ballarini T, Albrecht F, Mueller K, Jech R, Diehl-Schmid J, Fliessbach K, Kassubek J, Lauer M, Fassbender K, Schneider A, Synofzik M, Wiltfang J, Otto M, Schroeter ML (2020) Disentangling brain functional network remodeling in corticobasal syndrome - A multimodal MRI study. Neuroimage Clin 25:102112

Article  PubMed  Google Scholar 

Bayram E, Dickson DW, Reich SG, Litvan I (2020) Pathology-proven corticobasal degeneration presenting as Richardson’s syndrome. Mov Disord Clin Pract 7:267–272

Article  PubMed  PubMed Central  Google Scholar 

Belvisi D, Berardelli I, Suppa A, Fabbrini A, Pasquini M, Pompili M, Fabbrini G (2018) Neuropsychiatric disturbances in atypical parkinsonian disorders. Neuropsychiatr Dis Treat 14:2643–2656

Article  PubMed  PubMed Central  Google Scholar 

Berardelli I, Belvisi D, Pasquini M, Fabbrini A, Petrini F, Fabbrini G (2019) Treatment of psychiatric disturbances in hypokinetic movement disorders. Expert Rev Neurother 19:965–981

Article  CAS  PubMed  Google Scholar 

Bower SM, Weigand SD, Ali F, Clark HM, Botha H, Stierwalt JA, Whitwell JL, Josephs KA (2021) Depression and apathy across different variants of progressive supranuclear palsy. Mov Disord Clin Pract 9:212–217

Article  PubMed  PubMed Central  Google Scholar 

Bruns MB, Josephs KA (2013) Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy. Int Rev Psychiatry 25:197–209

Article  PubMed  Google Scholar 

Campagnolo M, Weis L, Fogliano C, Cianci V, Garon M, Fiorenzato E, Carecchio M, Ferreri F, Bisiacchi P, Antonini A, Biundo R (2023) Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes. J Neural Transm 130:97–109

Article  PubMed  Google Scholar 

Chendo I, Silva C, Duarte GS, Prada L, Vian J, Quintão A, Voon V, Ferreira JJ (2022) Frequency of depressive disorders in Parkinson’s disease: a systematic review and meta-analysis. J Parkinsons Dis 12:1409–1418

Article  CAS  PubMed  Google Scholar 

Cordato NJ, Halliday GM, McCann H, Davies L, Williamson P, Fulham M, Morris JG (2001) Corticobasal syndrome with tau pathology. Mov Disord 16:656–667

Article  CAS  PubMed  Google Scholar 

Cuoco S, Cappiello A, Abate F, Tepedino MF, Erro R, Volpe G, Pellecchia MT, Barone P, Picillo M (2021) Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy. Brain Behav 11:e2344

Article  PubMed  PubMed Central  Google Scholar 

Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I (2002) Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61:935–946

Article  CAS  PubMed  Google Scholar 

Dickson DW, Hauw JJ, Agid Y, Litvan I (2011) Progressive supranuclear palsy and corticobasal degeneration. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell Publishing Ltd., Oxford, pp 135–155

Chapter  Google Scholar 

Franceschi AM, Clifton M, Naser-Tavakolian K, Ahmed O, Cruciata G, Bangiyev L, Clouston S, Franceschi D (2020) ((18)F)-Fluorodeoxyglucose positron emission tomography/magnetic resonance imaging assessment of hypometabolism patterns in clinical phenotypes of suspected corticobasal degeneration. World J Nucl Med 20:176–184

PubMed  PubMed Central  Google Scholar 

Galts CPC, Bettio LEB, Jewett DC, Yang CC, Brocardo PS, Rodrigues ALS, Thacker JS, Gil-Mohapel J (2019) Depression in neurodegenerative diseases: common mechanisms and current treatment options. Neurosci Biobehav Rev 102:56–84

Article  PubMed  Google Scholar 

Gardner RC, Boxer AL, Trujillo A, Mirsky JB, Guo CC, Gennatas ED, Heuer HW, Fine E, Zhou J, Kramer JH, Miller BL, Seeley WW (2013) Intrinsic connectivity network disruption in progressive supranuclear palsy. Ann Neurol 73:603–616

Article  PubMed  PubMed Central  Google Scholar 

Garraux G, Salmon E, Peigneux P, Kreisler A, Degueldre C, Lemaire C, Destée A, Franck G (2000) Voxel-based distribution of metabolic impairment in corticobasal degeneration. Mov Disord 15:894–904

Article  CAS  PubMed  Google Scholar 

Geda YE, Boeve BF, Negash S, Graff-Radford NR, Knopman DS, Parisi JE, Dickson DW, Petersen RC (2007) Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. J Neuropsychiatry Clin Neurosci 19:77–80

Article  PubMed  Google Scholar 

Gerstenecker A, Duff K, Mast B, Litvan I (2013) Behavioral abnormalities in progressive supranuclear palsy. Psychiatry Res 210:1205–1210

Article  PubMed  Google Scholar 

Gibb WR, Luthert PJ, Marsden CD (1989) Corticobasal degeneration. Brain 112(Pt 5):1171–1192

Article  PubMed  Google Scholar 

Gupta R, Advani D, Yadav D, Ambasta RK, Kumar P (2023) Dissecting the relationship between neuropsychiatric and neurodegenerative disorders. Mol Neurobiol 60:6476–6529

Article  CAS  PubMed  Google Scholar 

Hirano S, Shinotoh H, Shimada H, Aotsuka A, Tanaka N, Ota T, Sato K, Ito H, Kuwabara S, Fukushi K, Irie T, Suhara T (2010) Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia. Brain 133:2058–2068

Article  PubMed  Google Scholar 

Huang KJ, Lu MK, Kao A, Tsai CH (2007) Clinical, imaging and electrophysiological studies of corticobasal degeneration. Acta Neurol Taiwan 16:13–21

PubMed  Google Scholar 

Illán-Gala I, Nigro S, VandeVrede L, Falgàs N, Heuer HW, Painous C, Compta Y, Martí MJ, Montal V, Pagonabarraga J, Kulisevsky J, Lleó A, Fortea J, Logroscino G, Quattrone A, Perry DC, Gorno-Tempini ML, Rosen HJ, Grinberg LT, Spina S, La Joie R, Rabinovici GD, Miller BL, Rojas JC, Seeley WW, Boxer AL (2022) Diagnostic accuracy of magnetic resonance imaging measures of brain atrophy across the spectrum of progressive supranuclear palsy and corticobasal degeneration. JAMA Netw Open 5:e229588

Article  PubMed  PubMed Central  Google Scholar 

Jabbari E, Holland N, Chelban V, Jones PS, Lamb R, Rawlinson C, Guo T, Costantini AA, Tan MMX, Heslegrave AJ, Roncaroli F, Klein JC, Ansorge O, Allinson KSJ, Jaunmuktane Z, Holton JL, Revesz T, Warner TT, Lees AJ, Zetterberg H, Russell LL, Bocchetta M, Rohrer JD, Williams NM, Grosset DG, Burn DJ, Pavese N, Gerhard A, Kobylecki C, Leigh PN, Church A, Hu MTM, Woodside J, Houlden H, Rowe JB, Morris HR (2020) Diagnosis across the spectrum of progressive supranuclear palsy and corticobasal syndrome. JAMA Neurol 77:377–387

Article  PubMed  Google Scholar 

Jellinger KA (2022) The pathobiological basis of depression in Parkinson disease: challenges and outlooks. J Neural Transm 129:1397–1418

Article  PubMed  Google Scholar 

Jellinger KA (2023a) Pathomechanisms of depression in progressive supranuclear palsy. J Neural Transm 130:1049–1056

Article  PubMed  Google Scholar 

Jellinger KA (2023b) Pathomechanisms of cognitive and behavioral impairment in corticobasal degeneration. J Neural Transm 130:1509–1522

Article  PubMed  Google Scholar 

Jo S, Oh JS, Cheong EN, Kim HJ, Lee S, Oh M, Kim JS, Chung SJ, Lee CS, Kwon M, Kang D, Lee JH (2021) FDG-PET patterns associated with ideomotor apraxia and imitation apraxia in patients with corticobasal syndrome. Parkinsonism Relat Disord 88:96–101

Article  PubMed  Google Scholar 

Koga S, Josephs KA, Aiba I, Yoshida M, Dickson DW (2022) Neuropathology and emerging biomarkers in corticobasal syndrome. J Neurol Neurosurg Psychiatry 93:919–929

Article  PubMed  Google Scholar 

Koga S, Metrick MA 2nd, Golbe LI, Santambrogio A, Kim M, Soto-Beasley AI, Walton RL, Baker MC, De Castro CF, DeTure M, Russell D, Navia BA, Sandiego C, Ross OA, Vendruscolo M, Caughey B, Dickson DW (2023) Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol Commun 11:88

Article  PubMed  PubMed Central